Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
C. Morrison, S. Pabla, J. Conroy, M. Nesline, S. Glenn, D. Dressman, A. Papanicolau‐Sengos, Blake Burgher, J. Andreas, V. Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, A. Omilian, W. Bshara, M. Zibelman, P. Ghatalia, K. Dragnev, K. Shirai, Katherine G. Madden, L. Tafe, Neel Shah, D. Kasuganti, L. de la Cruz-Merino, Isabel Araujo, Y. Saenger, M. Bogardus, M. Villalona-Calero, Zuanel Diaz, R. Day, M. Eisenberg, S. Anderson, I. Puzanov, L. Galluzzi, Mark Gardner, M. Ernstoff
Journal of Immunotherapy for Cancer